Abstract
Methoxyisobutylisonitrile (MIBI) is a technetium labeled compound introduced as an alternative to 201Tl for myocardial perfusion imaging. Because MIBI brain uptake is related not only to BBB disruption, as contrast enhancement on CT and MR scans, but also to the tumoral metabolic activity, 99mTc-MIBISPECT assists tumor grading evaluation, biopsy localization, and therapy monitoring, and permits differentiation of tumor recurrence from radiation necrosis. Moreover 99mTc-MIBISPECT is very helpful in distinguish the tumoral origin of cerebral hematoma. The reliability of this examination decreases over time and non-neoplastic ICH, showing no 99mTc-MIBI uptake within 2 days, can accumulate 99mTc-MIBI on more delayed imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
REFERENCES
Bagni, B., Pinna, L., Tamarozzi, R., Cattaruzzi, E., Marzola, M.C., Bagni, I., Ceruti, S., Valentini, A., Zanasi, A., Mavilla, L., Guerra, P.U., and Merli, A.G. (1995) SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl. Med. Commun. 16:258–264
Baldari, S., Restifo Pecorella, G., Cosentino, S., and Minutoli, F. (2002) Investigation of brain tumors with 99mTc-MIBI SPET. Q. J. Nucl. Med. 46:336 –345
Beauchesne, P., Pedeux, R., Boniol, M., and Soler, C. (2004) 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J. Nucl. Med. 3:409–413
Chan, J.H., and Peh, W.C. (1999) Methemoglobin suppression in T2-weighted pulse sequences: an adjunctive technique in MR imaging of hemorrhagic tumors. Am. J. Roentgenol. 173:13–14
Dethy, S., Goldman, S., Blecic, S., Luxen, A., Levivier, M., and Hildebrand, J. (1994) Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J. Nucl. Med. 35:1162–1166
Enzmann, D.R., Britt, R.H., Lyons, B.E., Buxton, J.L., and Wilson, D.A. (1981) Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. Am. J. Neuroradiol. 2:517–526
Filippi, L., Santoni, R., Manni, C., Danieli, R., Floris, R., and Schillaci, O. (2005) Imaging primary brain tumors by single-photon emission computerized tomography (SPECT) with technetium-99m sestamibi (MIBI) and tetrofosmin. Curr. Med. Imag. Rev. 1:61–66
Gaul, H.P., Wallace, C.J., and Crawley, A.P. (1996) Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction. Am. J. Neuroradiol. 17:1675–1680
Hanna, S.L., Langston, J.W., and Gronemeyer, S.A. (1991) Value of subtraction images in the detection of hemorrhagic brain lesions on contrast-enhanced MR images. Am. J. Neuroradiol. 12:681–685
Jeune, F.P., Dubois, F., Blond, S., and Steinling, M. (2005) Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J. Neurooncol. 29:1–7
Kinuya, K., Ohashi, M., Itoh, S., Yamamoto, K., Sakai, S., Kakuda, K., Nobata, K., Kato, N., Terahara, S., and Taki, S. (2002) Differential diagnosis in patients with ring-like thallium-201 uptake in brain SPECT. Ann. Nucl. Med. 16:417– 421
Maffioli, L., Gasparini, M., Chiti, A., Gramaglia, A., Mogioj, V., Pozzi, A., and Bombardieri, E. (1996) Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur. J. Nucl. Med. 23:308–311
Minutoli, F., Angileri, F.F., Cosentino, S., Restifo-Pecorella, G., Cardali, S., de Divitiis, O., Germanò, A., and Baldari, S. (2003) 99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma. J. Nucl. Med. 44:1566–1573
Minutoli, F., Angileri, F.F., Conti, A., Herberg, A., Aricò, D., Baldari, S., Cardali, S., de Divitiis, O., Germanò, A., and Baldari, S. (2005) Timing of examination affects reliability of 99mTc-methoxyisobutylisonitrile SPECT in distinguishing neoplastic from nonneoplastic brain hematomas. J. Nucl. Med. 46:574–579
Naddaf, S.Y., Akisik, M.F., Aziz, M., Omar, W.S., Hirschfeld, A., Masdeu, J., Donnenfeld, H., and Abdel-Dayem, H.M. (1998) Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients. Nucl. Med. Commun. 19:47–53
Nagamachi, S., Jinnouchi, S., Nabeshima, K., Nishii, R., Flores, L. 2nd, Kodama, T., Kawai, K., Tamura, S., Yokogami, K., Samejima, T., and Wakisaka, S. (2001) The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma – a comparative study with 201Tl. Neuroradiology 43:1023–1030
O’Tuama, L.A., Treves, S.T., Larar, J.N., Packard, A.B., Kwan, A.J., Barnes, P.D., Scott, R.M., Black, P.M., Madsen, J.R., Goumnerova, L.C., Sallan, S.E., and Tarbell, N.J. (1993) Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumours: a within-subject comparison. J. Nucl. Med. 34:1045–1051
Ogawa, T., Hatazawa, J., Inugami, A., Murakami, M., Fujita, H., Shimosegawa, E., Noguchi, K., Okudera, T., Kanno, I., and Uemura, K. (1995) Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. J. Nucl. Med. 36:2175–2179
Townsend, D.W., and Cherry, S.R. (2001) Combining anatomy and function: the path to true image fusion. Eur. Radiol. 11:1968–1974
Yokogami, K., Kawano, H., Moriyama, T., Uehara, H., Sameshima, T., Oku, T., Goya, T., Wakisaka, S., Nagamachi, S., Jinnouchi, S., and Tamura, S. (1998) Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET? Eur. J. Nucl. Med. 25:401–409
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Angileri, F.F., Minutoli, F., La Torre, D., Baldari, S. (2011). Hemorrhagic Brain Neoplasm – 99mTc-Methoxyisobutyl Isonitrile-Single Photon Emission Computed Tomography. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_17
Download citation
DOI: https://doi.org/10.1007/978-90-481-8665-5_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8664-8
Online ISBN: 978-90-481-8665-5
eBook Packages: MedicineMedicine (R0)